FILTER

FILTERED INTERVIEW RESULTS

Mining
Peru

Rafael Ravettino

GENERAL MANAGER, ACEROS CHILCA (MEPSA)
Aceros Chilca is focused on the production and commercialization of grinding media (balls) and castings mainly for the mining industry.
Mining
Peru

Francis McCann

GENERAL MANAGER – TORONTO, AMC CONSULTANTS
AMC Consultants explains how it is meeting increasing demand for its services in Peru despite the limitations imposed on contact caused by the pandemic.
Mining
Peru

Marcial Garcia

PARTNER AND MINING LEAD, EY PERU
EY Peru speaks with GBR about how Peru must reassure mining investors and the implications for mining of the country’s elections this year.
Mining
Peru

Raúl Ferrero

GENERAL MANAGER, FUCSA – FUNDICIÓN CHILCA S.A.
FUSCA in Chile relates how 2021 is making up for the lost business of 2020.
Mining
Peru

Fernando Barrio

GENERAL MANAGER, TECNOMINA
Tecnomina in Peru explains how it managed to achieve a bit of growth during a difficult year.
Mining
Peru

Jaime Solano

TECHNICAL SALES DIRECTOR, TORSA
TORSA is an R&D company based in Spain with more than 20 years of experience developing solutions for different sectors, such as renewable energy, logistics and mining.
Mining
Peru

Michael Cullen

MANAGING DIRECTOR - LATIN AMERICA, FTI CONSULTING
FTI Consulting speaks to GBR about the implications of Peru’s elections and COVID for the mining industry.
Mining
Peru

Roque Benavides

CHAIRMAN, BUENAVENTURA
Buenaventura comments on the political environment for mining in Peru and progress at its San Gabriel project.
Mining
Peru

Jorge Granda

GENERAL MANAGER PERU, AK DRILLING INTERNATIONAL
Ak Drilling comments on a revived junior sector in Peru as well as increased drilling contracts with brownfield producers looking to renew resources.
Mining
Peru

Giorgio Mosoni

CO-CEO, IPESA
IPESA explains how it is seeking to expand its market share in machinery for the Peruvian mining industry.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL